Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Sale of 5,549 KYMR shares, $587.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 5,549 | $587.0K |
| Jun 30, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 28,296 | $3.04M |
| Jun 26, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 37,179 | $4.45M |
| Jun 26, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 1,235 | $123.5K |
| Jun 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 6,068 | n/a |
| Jun 23, 2026 | Kymera Therapeutics, Inc. (KYMR) | Sale | 18,313 | $1.89M |
| Jun 23, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 11,741 | $234.8K |
| Jun 18, 2026 | Sionna Therapeutics, Inc. (SION) | Grant/Award | 17,340 | n/a |
| Apr 24, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 5,641 | $80.0K |
| Apr 16, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 4,159 | $59.0K |